Bio Path Holdings, Inc. financial data

Symbol
BPTH on Nasdaq
Industry
Pharmaceutical Preparations
Location
4710 Bellaire Boulevard, Suite 210, Bellaire, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
OGDEN GOLF CO CORP (to 2/19/2008)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 144 % -79.6%
Debt-to-equity 827 % +4734%
Return On Equity -2.84K % -1760%
Return On Assets -307 % -135%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 2.55M shares -77.7%
Common Stock, Shares, Outstanding 2.28M shares -71.3%
Entity Public Float 13.5M USD -51%
Common Stock, Value, Issued 2K USD -75%
Weighted Average Number of Shares Outstanding, Basic 1.61M shares +305%
Weighted Average Number of Shares Outstanding, Diluted 1.61M shares +305%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.73M USD -28.8%
General and Administrative Expense 4.31M USD -10.3%
Operating Income (Loss) -13M USD +23.6%
Nonoperating Income (Expense) 1.45M USD +14513%
Net Income (Loss) Attributable to Parent -11.6M USD +31.8%
Earnings Per Share, Basic -15.8 USD/shares +74.2%
Earnings Per Share, Diluted -15.8 USD/shares +74.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 739K USD -57.7%
Assets, Current 5.02M USD -19.8%
Property, Plant and Equipment, Net 48K USD -57.9%
Operating Lease, Right-of-Use Asset 51K USD -66.2%
Assets 5.12M USD -21.6%
Accounts Payable, Current 766K USD +20.1%
Accrued Liabilities, Current 2.19M USD +224%
Liabilities, Current 3.01M USD +111%
Operating Lease, Liability, Noncurrent 3K USD -96.5%
Liabilities 3.83M USD +158%
Retained Earnings (Accumulated Deficit) -113M USD -11.5%
Stockholders' Equity Attributable to Parent 1.29M USD -74.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.29M USD -74.4%
Liabilities and Equity 5.12M USD -21.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.27M USD
Net Cash Provided by (Used in) Financing Activities 7.22M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 2.28M shares -71.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.95M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.01M USD +16.3%
Deferred Tax Assets, Valuation Allowance 24.2M USD +26.3%
Deferred Tax Assets, Gross 24.2M USD +26.1%
Operating Lease, Liability 113K USD -48.9%
Depreciation 28K USD
Lessee, Operating Lease, Liability, to be Paid 119K USD -50.4%
Property, Plant and Equipment, Gross 1.12M USD 0%
Operating Lease, Liability, Current 55K USD -51.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 11K USD -89.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 108K USD -10.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 6K USD -68.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11K USD -85.5%
Deferred Tax Assets, Operating Loss Carryforwards 18.6M USD +17.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 114M USD +7.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 21K USD -50%
Share-based Payment Arrangement, Expense 900K USD 0%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%